Iontophoretic Terbinafine HCL 1.0% Delivery Across Porcine and Human Nails
暂无分享,去创建一个
H. Trau | Avner Shemer | Henri Trau | Boaz Amichai | M. Royz | Rachel Mosckovitz | Orit Sholto | Shirly Ben-Yaakov | Michael Royz | David Barak | Boaz Nitzan | A. Shemer | B. Amichai | R. Mosckovitz | David Barak | Orit Sholto | Shirly Ben-Yaakov | B. Nitzan
[1] S. K. Li,et al. Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis. , 2008, Journal of pharmaceutical sciences.
[2] Ju-Hyun Kim,et al. A Method to Measure the Amount of Drug Penetrated Across the Nail Plate , 2001, Pharmaceutical Research.
[3] S. N. Murthy,et al. Iontophoretic permselective property of human nail. , 2007, Journal of dermatological science.
[4] Senshang Lin,et al. Transdermal iontophoresis: impact on skin integrity as evaluated by various methods. , 2008, Critical reviews in therapeutic drug carrier systems.
[5] Kelly A. Smith,et al. Chemical method to enhance transungual transport and iontophoresis efficiency. , 2008, International journal of pharmaceutics.
[6] B. Elewski,et al. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. , 1997, Archives of dermatology.
[7] R. Hay,et al. A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis , 1987, Clinical and experimental dermatology.
[8] R. Hay,et al. Tioconazole nail solution—an open study of its efficacy in onychomycosis , 1985, Clinical and experimental dermatology.
[9] R. Hay,et al. Review of antifungal therapy and the severity index for assessing onychomycosis: Part I , 2008, The Journal of dermatological treatment.
[10] S. N. Murthy,et al. Trans-ungual iontophoretic delivery of terbinafine. , 2009, Journal of pharmaceutical sciences.
[11] N. Dixit,et al. Iontophoresis - an approach for controlled drug delivery: a review. , 2007, Current drug delivery.
[12] O. Corrigan,et al. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin. , 2007, International journal of pharmaceutics.
[13] J. Garduno,et al. Review of antifungal therapy, part II: Treatment rationale, including specific patient populations , 2008, The Journal of dermatological treatment.
[14] G. Petrányi,et al. Antifungal activity of the allylamine derivative terbinafine in vitro , 1987, Antimicrobial Agents and Chemotherapy.
[15] H. Trau,et al. Onychomycosis: rationalization of topical treatment. , 2008, The Israel Medical Association journal : IMAJ.
[16] D. Wiskirchen,et al. Iontophoretic drug delivery across human nail. , 2007, Journal of pharmaceutical sciences.
[17] D. Mehregan,et al. The cost effectiveness of testing for onychomycosis versus empiric treatment of onychodystrophies with oral antifungal agents. , 1999, Cutis.
[18] O. Corrigan,et al. Iontophoretic and chemical enhancement of drug delivery. Part I: across artificial membranes. , 2003, International journal of pharmaceutics.
[19] Aditya K. Gupta,et al. Therapies for onychomycosis: a review. , 2006, Dermatologic clinics.
[20] R. Scher. Onychomycosis: therapeutic update. , 1999, Journal of the American Academy of Dermatology.
[21] N. Ho. Professor William I. Higuchi: teacher and scientist. , 2008, Journal of pharmaceutical sciences.
[22] S. K. Li,et al. Mechanistic study of electroosmotic transport across hydrated nail plates: effects of pH and ionic strength. , 2008, Journal of pharmaceutical sciences.
[23] A. Shemer,et al. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study , 2010, The British journal of dermatology.
[24] B. Elewski,et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. , 2000, Journal of the American Academy of Dermatology.